Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY – Research Report), Waters (WAT – Research Report) and Biohaven Ltd. (BHVN – Research Report).
Alnylam Pharma (ALNY)
Alnylam Pharma received a Hold rating and a $165.00 price target from Cantor Fitzgerald analyst Olivia Brayer today. The company’s shares closed last Friday at $170.03.
According to TipRanks.com, Brayer is ranked #5172 out of 8712 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alnylam Pharma with a $226.69 average price target, a 33.7% upside from current levels. In a report issued on February 1, J.P. Morgan also maintained a Hold rating on the stock with a $170.00 price target.
See today’s best-performing stocks on TipRanks >>
Waters (WAT)
In a report issued on February 7, Brandon Couillard from Jefferies maintained a Hold rating on Waters, with a price target of $330.00. The company’s shares closed last Friday at $322.82.
According to TipRanks.com, Couillard is a 5-star analyst with an average return of
Currently, the analyst consensus on Waters is a Hold with an average price target of $322.09, implying a -1.1% downside from current levels. In a report issued on January 29, Robert W. Baird also maintained a Hold rating on the stock with a $289.00 price target.
Biohaven Ltd. (BHVN)
Piper Sandler analyst Christopher Raymond assigned a Buy rating to Biohaven Ltd. today and set a price target of $66.00. The company’s shares closed last Friday at $48.55, close to its 52-week high of $49.65.
According to TipRanks.com, Raymond is a 4-star analyst with an average return of
Currently, the analyst consensus on Biohaven Ltd. is a Strong Buy with an average price target of $48.75, a 3.5% upside from current levels. In a report issued on February 6, UBS also initiated coverage with a Buy rating on the stock with a $59.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALNY:
